Efficacy of bezafibrate for preventing myopathic attacks in patients with very long-chain acyl-CoA dehydrogenase deficiency.
Shiraishi H, Yamada K, Egawa K, Ishige M, Ochi F, Watanabe A, Kawakami S, Kuzume K, Watanabe K, Sameshima K, Nakamagoe K, Tamaoka A, Asahina N, Yokoshiki S, Kobayashi K, Miyakoshi T, Oba K, Isoe T, Hayashi H, Yamaguchi S, Sato N.
Shiraishi H, et al. Among authors: egawa k.
Brain Dev. 2021 Feb;43(2):214-219. doi: 10.1016/j.braindev.2020.07.019. Epub 2020 Aug 11.
Brain Dev. 2021.
PMID: 32798077